
Intero Biosystems wants drugmakers to test on mini human intestines,.
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology. Last two days at Disrupt are half off. Don’t miss any more moments. REGISTER NOW Disrupt doors open Oct. 13. Get your pass and bring someone with you at 50% off. REGISTER NOW. Drug development has long relied on animal models,.






